Sertraline Hydrochloride Tablet
Product Images NDC 51655-345

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 51655-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 345 26 Master Bottle Label Approval Rev A 05 20)

Label (51655 345 26 Master Bottle Label Approval Rev A 05 20)
Sertraline Hydrochloride Tablets, USP 25 mg oral tablets, supplied in a container of 90 tablets. The label specifies prescription use only, storage instructions, and includes details about dosage guidance, manufacturer Northwind Health Company, LLC, and the product NDC 51655-345-26.*
FDA Label Image

Chemical Structure (Sertraline Str)

Chemical Structure (Sertraline Str)
Chemical structure of Sertraline Hydrochloride showing the bicyclic ring system with two chlorine atoms on one aromatic ring and a methylammonium hydrochloride group attached to the other ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.